C 2012

MicroRNAs and Colorectal Cancer

SLABÝ, Ondřej, Marek SVOBODA and Rostislav VYZULA

Basic information

Original name

MicroRNAs and Colorectal Cancer

Authors

SLABÝ, Ondřej (203 Czech Republic, guarantor, belonging to the institution), Marek SVOBODA (203 Czech Republic) and Rostislav VYZULA (203 Czech Republic)

Edition

New York, MicroRNAs in Solid Cancer: From Biomarkers to Therapeutic Targets, p. 65-80, 16 pp. 2012

Publisher

Nova Science Publishers, Inc.

Other information

Language

English

Type of outcome

Kapitola resp. kapitoly v odborné knize

Field of Study

30200 3.2 Clinical medicine

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

Publication form

printed version "print"

RIV identification code

RIV/00216224:14740/12:00060171

Organization unit

Central European Institute of Technology

ISBN

978-1-61324-514-9

Keywords in English

microRNAs; colorectal cancer

Tags

Tags

International impact, Reviewed
Změněno: 13/3/2013 13:38, Olga Křížová

Abstract

V originále

Colorectal cancer (CRC) represents one of the most frequent causes of death for cancer. CRC has been recently defined as the third most common cancer. Polymorphisms within microRNAs binding regions have been described as new risk factors for CRC. Several genome-wide profiling studies have identified miRNAs deregulated in CRC tissue. Furthermore, number of experimental studies on these miRNAs revealed insight into miRNA-mediated, regulatory links to well-known oncogenic and tumor suppressor signaling pathways. Several investigations have also described the ability of specific miRNA expression profiles to predict prognosis and therapy response, and potential of selected miRNAs as therapeutical targets in CRC patients.

Links

ED1.1.00/02.0068, research and development project
Name: CEITEC - central european institute of technology